UBS Group AG - IDERA PHARMACEUTICALS INC ownership

IDERA PHARMACEUTICALS INC's ticker is IDRA and the CUSIP is 45168K405. A total of 35 filers reported holding IDERA PHARMACEUTICALS INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
UBS Group AG ownership history of IDERA PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2022$23,510
+193.9%
67,174
+200.5%
0.00%
Q3 2022$8,000
+33.3%
22,356
+70.2%
0.00%
Q2 2022$6,000
+20.0%
13,137
+29.1%
0.00%
Q1 2022$5,000
-44.4%
10,172
-39.5%
0.00%
Q4 2021$9,000
+28.6%
16,808
+147.0%
0.00%
Q3 2021$7,000
+250.0%
6,805
+390.3%
0.00%
Q2 2021$2,000
-50.0%
1,388
-58.7%
0.00%
Q1 2021$4,000
-81.8%
3,364
-43.5%
0.00%
Q4 2020$22,000
+57.1%
5,958
-7.9%
0.00%
Q3 2020$14,000
-6.7%
6,471
-24.1%
0.00%
Q2 2020$15,000
+66.7%
8,521
+20.1%
0.00%
Q1 2020$9,000
+12.5%
7,097
+55.2%
0.00%
Q4 2019$8,000
-60.0%
4,572
-34.0%
0.00%
Q3 2019$20,000
+5.3%
6,930
-3.3%
0.00%
Q2 2019$19,000
+171.4%
7,167
+159.0%
0.00%
Q1 2019$7,000
-83.3%
2,767
-81.7%
0.00%
Q4 2018$42,000
-46.2%
15,157
+73.9%
0.00%
Q3 2018$78,0008,7140.00%
Other shareholders
IDERA PHARMACEUTICALS INC shareholders Q3 2022
NameSharesValueWeighting ↓
ABG Innovation Capital Partners III GP Ltd 56,250$206,0000.12%
Baker Brothers Advisors 4,608,786$16,914,0000.06%
Artal Group S.A. 500,000$1,835,0000.04%
HOLLENCREST CAPITAL MANAGEMENT 90,000$331,0000.04%
Spotlight Asset Group, Inc. 21,500$79,0000.03%
DCF Advisers, LLC 18,755$69,0000.03%
683 Capital Management, LLC 88,470$325,0000.02%
Palo Alto Investors LP 77,044$283,0000.02%
Alpine Global Management, LLC 13,966$51,0000.01%
TCI Wealth Advisors, Inc. 4,000$15,0000.01%
View complete list of IDERA PHARMACEUTICALS INC shareholders